mRESVIA

Swiss trademark · 810533 · Combined mark · In force

Register entry

Registration number
810533
Application number
02506/2024
Status
In force
Type
Combined mark
As registered
mRESVIA ((fig.))
Filed
Feb 21, 2024
Registered
Feb 23, 2024
Published
Feb 23, 2024
Protected until
Feb 21, 2034
Language of procedure
German
Vienna classes
24.15.02, 24.15.15, 26.03.23, 26.07.18, 26.11.01, 26.11.08, 26.11.13
Source
Swissreg

Goods and services

Pharmaceuticals

Vaccines for human use

As filed

Impfstoffe für die Verwendung beim Menschen.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 11, 2026

    Pledge entered

    Pledgee
    Ares Capital Corporation, 245 Park Avenue, 44th Floor, New York 10167, USA

    Published in Swissreg on 11.05.2026

  2. Aug 15, 2024

    Holder’s address changed

    Owner
    ModernaTx, Inc., 200 Technology Square, 2nd Floor, Cambridge MA 02139, USA → ModernaTx, Inc., 325 Binney Street, Cambridge MA 02142, USA

    Published in Swissreg on 15.08.2024

  3. Feb 29, 2024

    Corrected

    Published in Swissreg on 29.02.2024

  4. Feb 23, 2024

    Registered

    Published in Swissreg on 23.02.2024

Parties

Holder

ModernaTx, Inc.

325 Binney Street, Cambridge MA 02142, US

Agent

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zürich

Pledgee

Ares Capital Corporation

245 Park Avenue 44th Floor, New York 10167, US

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.